STAAR Surgical Company

NASDAQ:STAA

Medical - Instruments & Supplies

Healthcare
$25.35 -1.37%

-$0.40 today

Market cap
$1.27B
Beta
1.23
P/E (TTM)
-68.3
EPS (TTM)
-$0.42
52W Low $15.59High $35.87

Volume 0.45M

Average 1.07M

STAA Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

STAAR Surgical CompanyNASDAQ: STAA

Cost of Revenue · Q1 FY2026 · quarter ended Apr 2026

Cost of revenue growth accelerates

Q1 FY2026 cost of revenue of $26M rose 78.3% year over year, ahead of the -5.7% change in trailing-twelve-month cost of revenue. Sequentially, it rose 84.9% from the prior quarter. Over 3 fiscal years it compounded at -2.2% a year.

Context

  • Cost of revenue amounted to 23.8% of revenue in FY2025, up 0.1 pp from a year earlier.
  • Cost of revenue increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +78.3% holds above the trailing-twelve-month pace of -5.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterApr 2026
$26M+84.9% QoQ
Last fiscal yearJan 2026
$57.02M-23.3% YoY
LTMApr 2026
$68.44M-5.7% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+78.3%——
1 year-23.3%——
3-year CAGR-2.2%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
57.02M USD
Year-over-year change
-23.3%
4-year CAGR
+2.4%

Cost of Revenue vs competitors

How STAA compares with its peers on the latest reported figures

  • STAA's LTM Apr 2026 cost of revenue of $68.44M is the 4th highest of the 5 companies compared; the peer median is $1.91B.
  • Its year-over-year change of -5.7% is the 4th highest of 5, against a peer median of +5.1%.
  • Cost of revenue amounts to 23.6% of revenue for STAA, versus a peer median of 39.5%.
STAA Competitors Peer median
Cost of Revenue for STAA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$4.67B +2.1%+5.5%42.7%
BLCOBausch + Lomb CorporationLTM Jun 2026$2.28B +8.0%+15.0%42.8%
COOThe Cooper Companies, Inc.LTM Jul 2026$1.54B +15.2%+11.3%36.4%
STAASTAAR Surgical CompanyLTM Apr 2026$68.44M -5.7%-2.2%23.6%
RXSTRxSight, Inc.LTM Mar 2026$29.3M -43.5%+4.4%23.0%
Peer median (excluding STAA) $1.91B+5.1%+8.4%39.5%

Competitors are the stored peer set for STAA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Revenue230.47M284.39M322.42M313.9M239.44M
Cost of Revenue51.84M61.01M69.76M74.32M57.02M
Gross Profit178.64M223.38M252.65M239.58M182.42M
Gross Margin77.5%78.5%78.4%76.3%76.2%
Research & Development33.86M35.98M44.4M53.97M40.06M
Selling, General & Admin111.44M143.6M180.15M198.22M188.31M
Operating Expenses145.3M179.58M224.55M252.19M228.37M
Depreciation & Amortization3.64M4.51M5.12M6.89M8.73M
EBITDA34.98M50.06M38.82M(2.16M)(73.54M)
EBITDA Margin15.2%17.6%12.0%-0.7%-30.7%
Operating Income33.34M43.8M28.1M(12.61M)(45.95M)
Operating Margin14.5%15.4%8.7%-4.0%-19.2%
Interest Income—2.45M6.99M5.91M4.59M
Interest Expense38K0000
Other Income / Expenses(2.04M)1.75M5.6M3.56M(36.32M)
Income Before Tax31.3M45.55M33.7M(9.05M)(82.26M)
Pre-Tax Margin13.6%16.0%10.5%-2.9%-34.4%
Income Tax Expense3.79M5.89M12.35M11.16M(1.82M)
Net Income27.51M39.67M21.35M(20.21M)(80.45M)
Net Margin11.9%13.9%6.6%-6.4%-33.6%
EPS (Basic)0.520.830.44(0.41)(1.62)
EPS (Diluted)0.500.800.43(0.41)(1.62)
Weighted Avg Shares47.21M47.99M48.52M49.13M49.57M
Weighted Avg Shares (Diluted)49.46M49.38M49.43M49.13M49.57M

STAAR Surgical Company

NASDAQ:STAA

Intrinsic Alpha fair value

Locked

Current Price

$25.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.